About Haystack Sciences
Haystack Sciences is a company based in San Francisco (United States) founded in 2016 by Richard Edward Watts was acquired by Insitro in October 2020. Haystack Sciences operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter San Francisco, United States
- Founders Richard Edward Watts
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Haystack Sciences
Investors in Haystack Sciences
Haystack Sciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Illumina and Insitro.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of technologies for analysis of genetic variation and function
|
Locked | Locked | Locked | |
|
An AI-enabled platform is developed for infectious disease treatment.
|
Locked | Locked | Locked |
Investor details for Haystack Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Haystack Sciences
Investment portfolio details for Haystack Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Haystack Sciences
Detailed financials for Haystack Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Haystack Sciences Comparisons
Peer comparison for Haystack Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Haystack Sciences
Haystack Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Haystack Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Haystack Sciences
Complete news archive for Haystack Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Haystack Sciences
Haystack Sciences was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Haystack Sciences is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Richard Edward Watts is the current CEO of Haystack Sciences. They have also founded this company.
Haystack Sciences was founded in 2016 in San Francisco, United States, as a small molecule drug discovery company. A proprietary platform is utilized to identify novel treatments for human diseases. Operations are conducted in stealth mode, with incubation provided by the Illumina Accelerator. The focus remains on advancing therapeutic development in the biotechnology sector.
Haystack Sciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.